Clinical trial
Effect of Oral Glutamine on Muscle Mass and Function in Duchenne Muscular…
NCT00296621 · Assistance Publique - Hôpitaux de Paris, Other · Completed
Key facts
| NCT number | NCT00296621 |
|---|---|
| Title | Effect of Oral Glutamine on Muscle Mass and Function in Duchenne Muscular Dystrophy |
| Official title | Efficacy Study of Oral Glutamine Supplementation in Duchenne Muscular Dystrophy |
| Acronym | MDB-GLN |
| Lead sponsor | Assistance Publique - Hôpitaux de Paris, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Muscular Dystrophy, Duchenne |
| Intervention type | Drug |
| Interventions | L-Glutamine, placebo |
| Enrollment | 30 |
| Start date | Feb 1, 2006 |
| Primary completion | Feb 1, 2008 |
| Completion | Nov 1, 2007 |
| First posted | Feb 27, 2006 |
| Last update posted | Dec 21, 2007 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: